WallStreetZenWallStreetZen

NASDAQ: LGVN
Longeveron Inc Stock

$3.89-0.66 (-14.51%)
Updated Jul 11, 2024
LGVN Price
$3.89
Fair Value Price
-$0.67
Market Cap
$24.70M
52 Week Low
$0.77
52 Week High
$37.50
P/E
-0.4x
P/B
8.12x
P/S
8.35x
PEG
N/A
Dividend Yield
N/A
Revenue
$978.00k
Earnings
-$20.82M
Gross Margin
48.5%
Operating Margin
-2,129.24%
Profit Margin
-2,210.8%
Debt to Equity
2.19
Operating Cash Flow
-$16M
Beta
1.23
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

LGVN Overview

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LGVN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

LGVN ($3.89) is overvalued by 676.89% relative to our estimate of its Fair Value price of -$0.67 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
LGVN ($3.89) is not significantly undervalued (676.89%) relative to our estimate of its Fair Value price of -$0.67 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
LGVN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more LGVN due diligence checks available for Premium users.

Be the first to know about important LGVN news, forecast changes, insider trades & much more!

LGVN News

Valuation

LGVN fair value

Fair Value of LGVN stock based on Discounted Cash Flow (DCF)
Price
$3.89
Fair Value
-$0.67
Undervalued by
676.89%
LGVN ($3.89) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
LGVN ($3.89) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
LGVN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

LGVN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.4x
Industry
-14.46x
Market
31.84x

LGVN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.12x
Industry
6.37x
LGVN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

LGVN's financial health

Profit margin

Revenue
$548.0k
Net Income
-$4.1M
Profit Margin
-740.5%
LGVN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
LGVN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$9.7M
Liabilities
$6.7M
Debt to equity
2.19
LGVN's short-term liabilities ($5.30M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LGVN's short-term assets ($3.76M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LGVN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.1M
Investing
$14.0k
Financing
$63.0k
LGVN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

LGVN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
LGVN$24.70M-14.51%-0.40x8.12x
UBX$24.68M+1.38%-0.64x1.03x
GANX$24.55M+13.33%-0.91x2.84x
SLGL$24.26M+1.63%-1.05x0.74x
IPA$25.21M-2.24%-2.33x0.69x

Longeveron Stock FAQ

What is Longeveron's quote symbol?

(NASDAQ: LGVN) Longeveron trades on the NASDAQ under the ticker symbol LGVN. Longeveron stock quotes can also be displayed as NASDAQ: LGVN.

If you're new to stock investing, here's how to buy Longeveron stock.

What is the 52 week high and low for Longeveron (NASDAQ: LGVN)?

(NASDAQ: LGVN) Longeveron's 52-week high was $37.50, and its 52-week low was $0.77. It is currently -89.63% from its 52-week high and 404.54% from its 52-week low.

How much is Longeveron stock worth today?

(NASDAQ: LGVN) Longeveron currently has 6,348,624 outstanding shares. With Longeveron stock trading at $3.89 per share, the total value of Longeveron stock (market capitalization) is $24.70M.

Longeveron stock was originally listed at a price of $74.10 in Feb 12, 2021. If you had invested in Longeveron stock at $74.10, your return over the last 3 years would have been -94.75%, for an annualized return of -62.56% (not including any dividends or dividend reinvestments).

How much is Longeveron's stock price per share?

(NASDAQ: LGVN) Longeveron stock price per share is $3.89 today (as of Jul 11, 2024).

What is Longeveron's Market Cap?

(NASDAQ: LGVN) Longeveron's market cap is $24.70M, as of Jul 12, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Longeveron's market cap is calculated by multiplying LGVN's current stock price of $3.89 by LGVN's total outstanding shares of 6,348,624.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.